Subscribe to:
POZ magazine E-newsletters
POZ Personals Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Life Expectancy With HIV Increases Dramatically
Strength Training Burns More Fat Than Endurance Exercise in HIV
New Anti-HIV Drug Target Discovered
A 'Functional Cure' for HIV?
Changing the HIV Treatment Paradigm
HIV Treatment Diminishes Non-AIDS Illnesses
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from CancerWEB's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Herpes Simplex Virus
Syphilis & Neurosyphilis
Shingles
The HIV Life Cycle
Human Papilloma Virus (HPV)
Treatments for Opportunistic Infections (OIs)
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailrssprint

August 20, 2008

Rapid Hep C Disease Progression in HIV-Positive Men

Rapid progression of liver disease shortly after becoming infected with hepatitis C virus (HCV), has been documented in a group of HIV-positive gay men, according to a study published in the September 1 issue of The Journal of Infectious Diseases.

When it comes to HIV and HCV coinfection, it matters which virus is contracted first. Researchers believe that most people coinfected with both viruses first contract HCV, followed by HIV. In such cases, the progression to serious disease requiring a liver transplant can take 20 or more years. Conversely, in people infected with HCV after they’ve experienced immune suppression due to HIV, progression to serious liver disease can occur in as little as three years.

Recently, there have been reports in Europe and the United States of clusters of HIV-positive gay men becoming infected with HCV. Though the routes of HCV transmission are not entirely clear, common elements among the men who became infected include unprotected anal sex, the use of club drugs, the presence of genital piercings, and rougher sex play such as fisting.

To evaluate possible transmission routes of HCV in HIV-positive men and the impact of HCV on the health of the liver during the initial weeks and months after infection, researchers from Mount Sinai School of Medicine in New York City began looking for signs of recent HCV infection in their HIV-positive patients. Under the direction of Daniel Fierer, MD, the researchers found 11 HIV-positive gay men who had signs of early HCV infection, including documented seroconversion from negative to positive on an HCV antibody test, extremely high liver enzyme levels and wildly fluctuating levels of HCV in the blood.

All of the men were first identified as having a possible recent HCV infection because of a sudden rise in the liver enzyme alanine aminotransferase (ALT). They ranged in age from 31 to 56 years old and had been HIV positive for between 9 months and 16 years. Ten reported unprotected anal sex, often with a number of men in the recent past, and three reported injecting methamphetamine.

Dr. Fierer’s team conducted liver biopsies on all the men to determine the extent of liver damage, known as fibrosis, which is given a score ranging from 0 for no damage up to 4 for end-stage liver disease. The biopsies were generally conducted within one year of the suspected HCV infection. Nine of the men had a fibrosis score of 2 at their first liver biopsy, indicating rapid progression of liver disease.

Though regular and routine screening for HCV antibodies are not currently a recommended part of general HIV care, the authors propose that such screening may be helpful in early identification of HCV infection in gay male patients. This would not only help identify outbreaks of HCV infection, but also allow for aggressive early treatment.

Search: HCV, hepatitis C, liver disease, Daniel Fierer, Mount Sinai, ALT


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include either ":" or "@" in your comment.)

| Posting Rules

Previous Comments:

comments 1 - 1 (of 1 total)    

Dennis V., San Franciso, 2008-08-21 13:30:27
I became co-infected and just competed 48 weeks of a study in which I was mega-dosed with Pegasus and co-Pegasus. I became undecttable by week 6 and remain so after 6 months after treatment end. My liver biopsy showed significant liver improvement from prior

comments 1 - 1 (of 1 total)    


[Go to top]

Get Started
Get Answers
I'm HIV positive. What's next?
How to find a support system
Things you should know before starting treatment
How to handle side effects and other concerns
How to tell someone you have HIV/AIDS

Conference Coverage

48th Annual ICAAC/IDSA 46th Annual Meeting
Washington, DC
October 25-28, 2008


XVII International AIDS Conference
Mexico City, Mexico
August 3-8, 2008


CROI 2008
Boston, MA
February 3-8, 2008


more conference coverage


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertise/contact us]
© 2008 Smart + Strong. All Rights Reserved. Terms of use and Your privacy